Chronic myeloid leukemia (CML) cells express an oncogene protein consisting of the gene fusion of BCR (Breakpoint Cluster Region) and the tyrosine kinase ABL (Abelson), which behaves as a potent inhibitor of apoptosis [7]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.